Literature DB >> 9204938

Adrenergic receptors in Alzheimer's disease brain: selective increases in the cerebella of aggressive patients.

A Russo-Neustadt1, C W Cotman.   

Abstract

In this study, the distribution and concentration of beta1, beta2, and alpha2 adrenergic receptors were examined in the frontal cortex, hypothalamus, and cerebellum of Alzheimer's disease (AD) and age-matched control human brains by receptor autoradiography. The purpose of this study was to detect changes in adrenergic receptor concentrations in key areas of the brain known to affect behavior. For these studies, [125I]iodopindolol ([125I]IPIN) was used to visualize total beta adrenergic sites (with ICI-89,406 and ICI-118, 551 as subtype-selective antagonists to visualize beta2 and beta1 receptors, respectively). [3H]UK-14,304 was used to localize the alpha2 sites. Essentially no significant difference in adrenergic receptor concentration was found between total AD cases taken together and control patients. It was found, however, that there were important distinctions within the AD group when cases were subdivided according to the presence or absence of aggression, agitation, and disruptive behavior. Aggressive AD patients had markedly increased (by approximately 70%) concentrations of alpha2 receptors in the cerebellar cortex compared with nonaggressive patients with similar levels of cognitive deficit. The levels of cerebellar alpha2 receptors in aggressive AD patients were slightly above the healthy elderly controls, suggesting that these receptors are preserved and perhaps increased in this subgroup of AD. beta1 And beta2 adrenergic receptors of the cerebellar cortex showed smaller but significant ( approximately 25%) increases in concentration in aggressive AD subjects versus both nonaggressive AD patients and controls. No significant differences were found in adrenergic receptor concentrations within the frontal cortex or hypothalamus. These results point out the importance of distinguishing behavioral subgroups of AD when looking for specific neurochemical changes. These autoradiographic results may reflect the importance of the cerebellum in behavioral control.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9204938      PMCID: PMC6793809     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  42 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Localization and quantification of beta-adrenergic receptors in human brain.

Authors:  G A Reznikoff; S Manaker; C H Rhodes; A Winokur; T C Rainbow
Journal:  Neurology       Date:  1986-08       Impact factor: 9.910

3.  The thalamic afferents to the inferior parietal lobule of the rhesus monkey.

Authors:  D L Kasdon; S Jacobson
Journal:  J Comp Neurol       Date:  1978-02-15       Impact factor: 3.215

4.  Characterization of beta-adrenergic receptors on human cerebral microvessels.

Authors:  H Kobayashi; L Frattola; C Ferrarese; P Spano; M Trabucchi
Journal:  Neurology       Date:  1982-12       Impact factor: 9.910

5.  Altered sensitivity of forebrain neurones to iontophoretically applied noradrenaline in aging rats.

Authors:  R S Jones; H R Olpe
Journal:  Neurobiol Aging       Date:  1983       Impact factor: 4.673

6.  Adrenergic receptors in aging and Alzheimer's disease: increased beta 2-receptors in prefrontal cortex and hippocampus.

Authors:  R N Kalaria; A C Andorn; M Tabaton; P J Whitehouse; S I Harik; J R Unnerstall
Journal:  J Neurochem       Date:  1989-12       Impact factor: 5.372

7.  Physical aggression is associated with preservation of substantia nigra pars compacta in Alzheimer disease.

Authors:  J Victoroff; C Zarow; W J Mack; E Hsu; H C Chui
Journal:  Arch Neurol       Date:  1996-05

8.  The effect of lithium on impulsive aggressive behavior in man.

Authors:  M H Sheard; J L Marini; C I Bridges; E Wagner
Journal:  Am J Psychiatry       Date:  1976-12       Impact factor: 18.112

9.  Propranolol for the control of disruptive behavior in senile dementia.

Authors:  P G Weiler; D Mungas; C Bernick
Journal:  J Geriatr Psychiatry Neurol       Date:  1988 Oct-Dec       Impact factor: 2.680

10.  Propranolol for treatment of agitation in senile dementia.

Authors:  M E Pauszek
Journal:  Indiana Med       Date:  1991-01
View more
  23 in total

Review 1.  Amyloid beta peptide membrane perturbation is the basis for its biological effects.

Authors:  J N Kanfer; G Sorrentino; D S Sitar
Journal:  Neurochem Res       Date:  1999-12       Impact factor: 3.996

2.  Neuron specific alpha-adrenergic receptor expression in human cerebellum: implications for emerging cerebellar roles in neurologic disease.

Authors:  U B Schambra; G B Mackensen; M Stafford-Smith; D E Haines; D A Schwinn
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

3.  Effects of dietary supplementation with N-acetyl cysteine, acetyl-L-carnitine and S-adenosyl methionine on cognitive performance and aggression in normal mice and mice expressing human ApoE4.

Authors:  Amy Chan; Thomas B Shea
Journal:  Neuromolecular Med       Date:  2007       Impact factor: 3.843

Review 4.  Resistance, vulnerability and resilience: A review of the cognitive cerebellum in aging and neurodegenerative diseases.

Authors:  Katharine J Liang; Erik S Carlson
Journal:  Neurobiol Learn Mem       Date:  2019-01-07       Impact factor: 2.877

Review 5.  Neurotransmitter receptors and cognitive dysfunction in Alzheimer's disease and Parkinson's disease.

Authors:  Yunqi Xu; Junqiang Yan; Peng Zhou; Jiejie Li; Huimin Gao; Ying Xia; Qing Wang
Journal:  Prog Neurobiol       Date:  2012-02-25       Impact factor: 11.685

6.  β2-adrenergic receptor and astrocyte glucose metabolism.

Authors:  Jun-hong Dong; Xin Chen; Min Cui; Xiao Yu; Qi Pang; Jin-peng Sun
Journal:  J Mol Neurosci       Date:  2012-03-08       Impact factor: 3.444

7.  Binding of amyloid beta peptide to beta2 adrenergic receptor induces PKA-dependent AMPA receptor hyperactivity.

Authors:  Dayong Wang; G Govindaiah; Ruijie Liu; Vania De Arcangelis; Charles L Cox; Yang K Xiang
Journal:  FASEB J       Date:  2010-04-15       Impact factor: 5.191

8.  Psychosis Due to Neurologic Conditions.

Authors:  David B. Arciniegas; Jeannie L. Topkoff; Kerri Held; Lauren Frey
Journal:  Curr Treat Options Neurol       Date:  2001-07       Impact factor: 3.598

9.  Disruptive behavior as a predictor in Alzheimer disease.

Authors:  Nikolaos Scarmeas; Jason Brandt; Deborah Blacker; Marilyn Albert; Georgios Hadjigeorgiou; Bruno Dubois; Davangere Devanand; Lawrence Honig; Yaakov Stern
Journal:  Arch Neurol       Date:  2007-12

10.  Dietary and genetic compromise in folate availability reduces acetylcholine, cognitive performance and increases aggression: critical role of S-adenosyl methionine.

Authors:  A Chan; F Tchantchou; V Graves; R Rozen; T B Shea
Journal:  J Nutr Health Aging       Date:  2008-04       Impact factor: 4.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.